News

Photo
18.01.2023 • News

Ineos to Acquire MBCC’s Admixtures Business

Ineos Enterprises has signed an agreement to buy MBCC Group’s admixture business from Sika. The deal is required by European antitrust regulators to approve Sika’s purchase of the MBCC Group, formerly BASF Construction Chemicals. The transaction is scheduled to complete in the first half of this year, subject to regulatory approvals.

Photo
18.01.2023 • News

Bayer Shifting Pharma Focus away from Europe

Bayer is increasingly shifting the commercial focus of its pharmaceutical business away from Europe and toward the US and China, Stefan Oelrich, head of the German group’s pharmaceuticals arm, said in an interview with Financial Times during the JPMorgan Healthcare conference in San Francisco.

Photo
18.01.2023 • News

Stolthaven Opens Taiwan Terminal

Stolthaven Terminals and partner Revivegen Environmental Technology have opened their joint venture terminal in Taiwan. The facility, operated by Stolthaven Revivegen Kaohsiung Terminal (SHRVK), will meet growing customer demand in the region and also introduce more international trade to Taiwan, the partners said.

Photo
17.01.2023 • News

Germany Opens Second LNG Import Terminal

Germany inaugurated its second liquefied natural gas (LNG) import terminal on Jan. 14 in the Baltic seacoast town of Lubmin, in the presence of chancellor Olaf Scholz and Manuela Schwesig, prime minister of the state of Mecklenburg-Western Pomerania.

Photo
17.01.2023 • News

Resilience and Mubadala in Biopharma Venture

US biopharma manufacturing and technology company National Resilience has entered into an agreement with Abu Dhabi investor Mubadala Investment Company to build a manufacturing plant in the United Arab Emirate’s biggest city. This will be the first GMP biopharma facility in the UAE.

Photo
16.01.2023 • News

Tsubame BHB Wins Order for Ammonia Synthesis Facility

The aim of Tokyo, Japan-headquartered Tsubame BHB is to commercialize on-site ammonia production at small-scale plants using an electride-based catalyst. The Company now received an order from Daiichi Jitsugyo for an ammonia synthesis facility to be introduced for the integrated demonstration test of blue hydrogen and ammonia production/utilization conducted by Inpex in Kashiwazaki in Japan’s Niigata Prefecture.

Photo
16.01.2023 • News

BioNTech to Acquire all of InstaDeep

As it continues to leverage earnings from its top-selling mRNA-based Covid vaccine to deepen its existing knowhow, Mainz, Germany-based BioNtech has announced plans to acquire all of London-based artificial intelligence specialist InstaDeep.

Photo
16.01.2023 • News

Chemours Invests in Ion Exchange Materials

US specialty chemicals and materials company Chemours will spend $200 million to increase capacity for its Nafion ion exchange membranes at its site in Villers-Saint-Paul, France.

Photo
16.01.2023 • News

Venator Investor Seeks Urgent Board Change

Venator’s second-largest investor, Czech private equity fund J&T MS 1 SICAV, is asking for a seat on the board of the UK-headquartered multinational pigments and additives producer, citing major concerns about its financial underperformance and massive shareholder value destruction.

Photo
13.01.2023 • News

Fluid Energy Sells Acid Business to Dorf Ketal

Canada’s Fluid Energy Group has sold its global modified and synthetic acid business, including the Triton industrial business, to Dorf Ketal FZE, a wholly owned subsidiary of Dorf Ketal Chemicals India, for an undisclosed sum.

Photo
13.01.2023 • News

Bayer Draws Attention from Activist Investors

As Bayer’s board prepares to search for a new CEO to succeed Werner Baumann, the German pharmaceuticals and agrochemicals group has attracted the attention of two activist investors interested in pulling its share price out of the doldrums and reaping the rewards.

Photo
12.01.2023 • News

Yara Modifies German Ammonia Terminals

Yara has announced plans to modify its ammonia terminals in Germany to help speed up the country’s hydrogen economy. CEO Svein Tore Holsether said the company has identified “substantial potential” to increase ammonia imports to Germany in line with growing market demand.

Photo
12.01.2023 • News

AstraZeneca Buys CinCor Pharma

AstraZeneca has entered into an agreement to buy CinCor Pharma, a US-based clinical-stage biopharma focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease.

Photo
12.01.2023 • News

EuroAPI Invests €40 Million in French B12 Production

Leading active pharmaceutical ingredients manufacturer EuroAPI plans to invest €40 million at its site in Saint-Aubin-lès-Elbeuf, France, to launch a new production technology for vitamin B12. Full capacity is expected to be reached by 2027.

Photo
11.01.2023 • News

Qatar Greenlights new Ras Laffan Project

QatarEnergy said it has made a final decision to go ahead with delayed $6 billion Ras Laffan Petrochemicals Complex to be realized with US multinational partner Chevron Phillips Chemical (CPChem).

Photo
11.01.2023 • News

Vopak and Hydrogenious in Hydrogen Venture

Vopak and Hydrogenious LOHC Technologies are forming a joint venture company to accelerate the development of an international hydrogen market. The 50:50 venture, LOHC Logistix, will be based in Germany, supporting both partners’ efforts to supply green hydrogen.

Photo
10.01.2023 • News

German Merck Licenses Fusion Protein to PDS

Germany‘s Merck has granted an exclusive license for the tumor-targeting IL-12 fusion protein currently known as M9241 to PDS Biotechnology Corporation, a US-based clinical-stage immunotherapy company with a growing pipeline of targeted immunotherapies for cancer and infectious disease.

Photo
10.01.2023 • News

KBR Wins Indian VAM Project

US-based multinational contractor KBR and its Japanese acetyls technology partner Showa Denko have been selected by Asian Paints to provide services for a grassroots vinyl acetate monomer (VAM) plant in India.

Photo
10.01.2023 • News

Viatris Forms Eye Care Unit from Acquisitions

Viatris, formed in November 2020 from the merger of Mylan with Pfizer’s Upjohn division, has established an eye care division following the closure of two acquisitions on Jan. 3.

Photo
09.01.2023 • News

CEFIC Concerned by Revision of EU CLP Regulation

On December 19, 2022, the European Commission proposed a revised regulation on Classification, Labelling and Packaging (CLP) of chemicals and introduced new hazard classes for endocrine disruptors, as well as for chemicals that do not break down in the environment and can accumulate in living organisms, or risk entering and spreading across the water cycle, including drinking water.

Photo
06.01.2023 • News

Moderna Buys Japan’s OriCiro Genomics

In its first acquisition since forming in 2010, mRNA specialist Moderna is buying Japan’s OriCiro Genomics for $85 million, expanding its therapeutics and vaccines portfolio.

Photo
06.01.2023 • News

Arkema Completes Divestment of Febex

Arkema has finalized the divestment of Febex, a company specialized in phosphorus-based chemistry, as a further step in what it calls its ”dynamic portfolio management strategy.” Buyer is Belgian group Prayon; the acquisition price was not disclosed.

Photo
06.01.2023 • News

ADNOC to Take a 24.9% Stake in OMV

In a deal announced shortly before Christmas that only attracted significant attention in the new year, Abu Dhabi National Oil Company (ADNOC) said it is acquiring a 24.9% stake in Austrian energy group OMV from Mubadala, the sovereign wealth fund of the United Arab Emirates.

Photo
05.01.2023 • News

Nouryon Closes ADOB Acquisition

Nouryon announced on Jan. 4 that it had closed its purchase of ADOB, a Poland-based supplier of chelated micronutrients, foliars and other specialty agricultural solutions.

Photo
05.01.2023 • News

Novartis to Pay $245 Million in ’Pay for Delay’ Settlement

Novartis has agreed to pay a total of $245 million to settle lawsuits filed by direct purchasers, indirect purchasers and retailers accusing it of colluding with Par Pharmaceutical to delay the launch of a generic version of its Exforge (valsartan/amlodipine) hypertension drug.

Photo
04.01.2023 • News

Brenntag and Univar Call off ’Engagement’

German distribution giant Brenntag is retreating from plans to acquire US rival Univar. The company said in an ad hoc statement that it is “no longer pursuing these discussions.”

Photo
04.01.2023 • News

Biden EPA Revives Waters of the United States

Just before the New Year, the administration of US president Joe Biden revived Waters of the United States, a section of former president Barack Obama’s Clean Air Act that had been deleted by Donald Trump in a move rejected by a federal court.

Photo
23.12.2022 • News

ExxonMobil Starts up Advanced Recycling Plant

ExxonMobil has started up what it says is one of the largest advanced recycling facilities in North America at its integrated manufacturing complex in Baytown, Texas, where the company uses proprietary Exxtend technology to break down hard-to-recycle plastics and process them into chemical feedstock.

Photo
23.12.2022 • News

3M Announces Exit from PFAAS

US consumer products giant 3M has announced it will discontinue production and use of perfluoroalkyl and polyfluoroalkyl substances, (PFAS) across its products by the end of 2025.

Photo
23.12.2022 • News

Arkema Doubles Polyester Resin Output in India

Arkema has doubled capacity for its Reafree-branded powder polyester resins at its Navi Mumbai facility in India. The French chemical producer said the upgrade reinforces its leadership position in the global powder coatings market and its commitment to developing very low-VOC technologies.

Photo
22.12.2022 • News

New German Hydrogen Pipeline Network in Planning

German utility companies Gascade, Ontras and Terranets BW are planning to create a 1,100 km pipeline system with up to 20 GW capacity to transport renewable hydrogen across the country from north to south.

12415 more News

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.